Ligand validation:4IXR

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

SQD is a Ligand Of Interest in 4IXR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IXR_SQD_A_417	5%	35%	0.373	0.778	1.01	1.63	4	12	0	0	100%	1
4IXR_SQD_a_401	3%	35%	0.427	0.755	0.99	1.66	4	10	0	0	100%	1
4IXR_SQD_A_413	3%	37%	0.393	0.727	0.98	1.54	3	10	0	0	94%	0.9444
4IXR_SQD_a_415	3%	37%	0.385	0.71	0.97	1.57	4	10	0	0	94%	0.9444
4IXR_SQD_b_601	2%	35%	0.414	0.675	1.02	1.62	5	9	0	0	87%	0.8704
4IXR_SQD_B_626	2%	36%	0.42	0.678	1.03	1.57	5	10	0	0	87%	0.8704
4IXR_SQD_f_102	1%	34%	0.596	0.751	1.02	1.68	4	11	0	0	83%	0.8333
4IXR_SQD_D_408	0%	27%	0.664	0.719	1.11	1.99	5	10	0	0	80%	0.7963
4IXR_SQD_F_102	0%	34%	0.761	0.693	1.04	1.67	5	10	0	0	83%	0.8333
4IXR_SQD_d_408	0%	27%	0.738	0.641	1.12	1.98	4	10	0	0	80%	0.7963
5V2C_SQD_a_413	94%	24%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	77%	23%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	32%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	75%	33%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	75%	32%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	33%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.